Intravenous Dexamethasone and intravenous lidocaine in children undergoing cleft palate surgery

Phase 3

• Conditions: Respiratory and hemodynamic complications in the cleft palate.; Cleft palate; Cleft lip; Cleft palate with cleft lip; Q35; Q36

• Registration Number: IRCT20160301026866N8
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 115

Inclusion Criteria

Six months to two years children
with ASA class I and II
without underlying illness
candidate for Cleft palate surgery

Exclusion Criteria

The presence of symptoms of upper respiratory tract infection
Coagulation disorder
Systemic diseases
other hereditary abnormalities

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean arterial blood pressure. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Heart rate. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Respiratory complications(Larangospasm, bronchospasm, coughing). Timepoint: in the recovery room. Method of measurement: Recording the complications.;Intensity of pain. Timepoint: Every 15 minutes in recovery room. Method of measurement: Visual Analogue Scale.